The nuclear medicine group at the University of Heidelberg in Germany recently reported a complete response in two patients treated with Ac-225-PSMA-617 (see this link). … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: actinium-225, experimenta;l, outcome, PSMA-617 | 6 Comments »